The lack of widely accepted, standardized, clinical and epidemiologic crite
ria for Multiple Chemical Sensitivity syndrome has led to confusion about t
he identification of the condition and has slowed pertinent research. In th
is article, the authors evaluated the psychometric properties of 2 sets of
clinical/epidemiologic criteria for Multiple Chemical Sensitivity syndrome.
In this cross-sectional survey of 1,166 patients who visited outpatient oc
cupational, otolaryngology, allergy, and clinical ecological clinics, the a
uthors used the aforementioned sets of criteria to (a) estimate the prevale
nce of the syndrome in these varied samples and (b) compare the current dia
gnostic practices of traditional physician specialists with those of clinic
al ecologists. The authors used a patient-completed questionnaire to assess
the medical, psychosocial, and psychological status of patients who report
ed multiple chemical sensitivities. This approach enabled the formulation o
f 6 domains, which represented commonly observed characteristics of the syn
drome. The authors used a physician-completed questionnaire to collect diag
noses of Multiple Chemical Sensitivity syndrome and other medical condition
s. Domains, which were operationalized by the questionnaire and comprised t
he 2 sets of criteria for identification of the Multiple Chemical Sensitivi
ty syndrome, had test-retest reliabilities that exceeded .75 and estimates
of internal consistency that ranged between .59 and .94. Evidence of constr
uct and face validity was considered acceptable. The overall clinic-based p
revalences of Multiple Chemical Sensitivity syndrome, based on 6 and 4 doma
ins, were 7% and 23%, respectively. Regardless of the identifying set of cr
iteria used, physicians' diagnoses had relatively low sensitivities (range
= 6-50%) and relatively high specificities (range = 82-99%). The study data
suggested that the domains operationalized by the questionnaire had reason
able psychometric characteristics. Study data also support the fact that Mu
ltiple Chemical Sensitivity syndrome is often overlooked-even by those phys
icians who treat it most frequently-and that use of both sets of objective
criteria for identifying the syndrome would greatly improve the sensitivity
of physician diagnoses.